Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:49 PM
Ignite Modification Date:
2025-12-24 @ 5:49 PM
NCT ID:
NCT00014768
Eligibility Criteria:
PROTOCOL ENTRY CRITERIA:
--Disease Characteristics--
* Diagnosis of cystic fibrosis (CF) and pregnant OR Age, weight, and body mass index matched non-pregnant CF woman or pregnant non-CF woman
* No infection with Burkholderia cepacia
* FEV1 at least 60%
--Prior/Concurrent Therapy--
* At least 3 weeks since prior corticosteroids
--Patient Characteristics--
* Hepatic: No more than one transaminase level greater than 10% above normal
Other:
Pregnant non-CF controls:
* No cigarette smokers
* No history of gestational diabetes mellitus
* No type 1 or 2 diabetes
* No other chronic illness
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
0 Years
Study:
NCT00014768
Study Brief:
Protocol Section:
NCT00014768